The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
Never seen so many clueless trolls pop up (all in filter) - would prefer to listen to GM and the fantastic RNS and Numis’s updated Broker note - base case SP 1365p (without any new contracts which I believe will come in next few weeks, possibly days).
Smart money buying below 1000p for a 40% plus near term return, much more when new contracts come).
Just how undervalued is Novacyt vs. Biosynex (another Covid testing company in France)??
Biosynex around 15% ebidta and about 23 P/E ratio
Nova about 80% ebidta and currently about 4 P/E ratio
On a like for like Novacyt is OVER 5 times undervalued ie. it should be over £50 to match Biosynex.
(Novacyt’s PE of 4 is based on a low £200 million earnings and £800 million MCAP)
By the way a PE of 30 is about average for the diagnostics industry - AstraZeneca has a PE of over 100 door example.
https://www.reuters.com/article/us-health-coronavirus-testing-idUSKBN29D2IZ
As Thermo Fisher’s tests are struggling with detecting the new strains I would be surprised if NCYT hasn’t increased it’s percentage as picks up all variants and will be front and centre for the new centres due to the great detection.
Possibly a new partner - good to see them pushing Novacyt’s ability to detect all known variants... unlike some competitors.
https://afsbio.com/blogs/news/novacyt-covid-19-diagnostic-tests-remain-able-to-detect-all-published-virus-strains?fbclid=IwAR1FzJLMIiMFGdbfLfbcIKf1_wLr1gzaxVVQY8DP0Tvoq3PgkKwuITfmkaw
Should help the SP!
France to do at least one million COVID-19 tests per month in schools: PM
By Reuters Staff
FILE PHOTO: A placard which reads "Covid-19 PCR test : come and get tested for free and without an appointment" is seen at the elementary school Maurice Thorez in Bagneux, France, January 8, 2021. REUTERS/Gonzalo Fuentes
PARIS (Reuters) - France will carry out at least one million COVID-19 tests per month in schools as part of a strategy to keep them open during the pandemic, Prime Minister Castex said on Thursday,
He also told a news conference that from Jan. 25 first-year students in higher education will be allowed to attend courses on campuses in small groups.
Reporting by Geert de Clercq and Dominique Vidalon; Editing by Mark Heinrich
Our Standards: The Thomson Reuters Trust Principles.
https://www.bbc.co.uk/news/resources/idt-b6360f40-84f9-469b-b6a3-a4568e161c4f
Well worth a read...
Increased Intensity Of PCR Testing Reduced COVID-19 Transmission Within Countries During The First Pandemic Wave.
Experts agree that reverse transcription–polymerase chain reaction (PCR) testing is critical in controlling coronavirus disease 2019 (COVID-19), but decision-makers disagree on how much testing is optimal. Controlling for interventions and ecological factors, we used linear regression to quantify testing’s impact on COVID-19’s average reproduction number, representing transmissibility, in 173 countries and territories, accounting for 99% of the world’s COVID-19 cases, during March to June 2020. Amongst interventions, PCR testing had the greatest influence—a ten-fold increase in the ratio of tests to new cases reported reduced the average reproduction number by 9% across a range of testing levels. Our results imply that mobility reductions (e.g., shelter-in-place orders) were less effective in developing countries than in developed countries. Our results help explain how some nations achieved near-elimination of COVID-19 and the failure of lockdowns to slow COVID-19 in others. Our findings suggest that World Health Organization and other testing benchmarks are insufficient for COVID-19 control. Increased testing and isolation may represent the most effective, least costly alternative in terms of money, economic growth and human life for controlling COVID-19. [Editor’s Note: This Fast Track Ahead Of Print article is the accepted version of the peer-reviewed manuscript. The final edited version will appear in an upcoming issue of Health Affairs.
RE: IndependentToday 18:27
Government’s response to inaccurate Independant article (which is a rehash of article published 4 weeks ago - they have NCYT’s back...
Since then GM etc have bought over £600,000 worth of shares.
I believe this has been planted to panic investors into selling cheaply.
Personally I’ll be buying more on any drop as I normally do on a Monday and Tuesday - I think makes stage 2 and care home contracts virtually in the bag and close - next week or week after IMO.
“The government has insisted that the rollout is not being stopped and that there are no plans to remove the existing machines, some of which have been validated and are now providing rapid testing for hospital patients and staff.
A spokesperson for the government said: “All the testing technologies used in NHS hospitals have been clinically validated and are highly accurate.”
Government’s response to inaccurate Independant article (which is a rehash of article published 4 weeks ago - they have NCYT’s back...
Since then GM etc have bought over £600,000 worth of shares.
I believe this has been planted to panic investors into selling cheaply.
Personally I’ll be buying more on any drop as I normally do on a Monday and Tuesday - I think makes stage 2 and care home contracts virtually in the bag and close - next week or week after IMO.
“The government has insisted that the rollout is not being stopped and that there are no plans to remove the existing machines, some of which have been validated and are now providing rapid testing for hospital patients and staff.
A spokesperson for the government said: “All the testing technologies used in NHS hospitals have been clinically validated and are highly accurate.”
By Sharon Brennan 24 November 2020
Health secretary Matt Han**** said the mass diagnostic capacity built up to deal with covid must be used for “everything” in the future
He said if you have flu symptoms “you should have a test and find out what is wrong with you”
Speaking at Commons health and social care committee he said the British culture of “soldiering on” when ill must “change”
Matt Han**** has called for British people to routinely get tested for the flu, saying covid diagnostic capacity should be kept and used for “everything” once the pandemic dies down.
Speaking at the Commons health and social care committee this morning, the health and social care secretary said the nation “must hold on to” the mass diagnostic capacity it has created for coronavirus.
Going further, he called for a change in culture to one of “if in doubt, you get a test”, and for a long-term expansion of diagnostics.
Mr Han**** said: “Why in Britain do we think it’s acceptable to solider on when you have flu symptoms or a runny nose, and go in [to work] and make everyone ill?
“If you have flu-like symptoms you should have a test for it and find out what is wrong with you and stay at home. We are peculiar outliers in soldiering on and going to work and that… culture, that should change.”
While there are tests available to diagnose influenza, they are rarely used for community cases, and some people have questioned their accuracy. Antiviral drugs can be used to reduce the severity of flu but are not given regularly for mild flu symptoms.
Mr Han****, in the same session, called for diagnostic capacity to be “core” to how the NHS treats people in the future.
He said after the covid vaccine has been distributed, the mass labs created for covid PCR tests be used “not just for covid but for everything. I want to have a change in the British way of doing things [to one where] if in doubt, you get a test. This doesn’t just refer to covid but to any illness you may have.”
He added: “I want this massive diagnostic capacity to be core in how we treat people in the NHS so that we help people to stay healthy in the first place rather than just looking after them when they’re ill.”
In recent years NHS England and others have pointed to under-capacity of CT and MRI scanners in the country; while others have been calling for expansion of the diagnostic workforce. Improving early diagnosis is important for improving cancer and other outcomes, but capacity is limited, meaning long waits for many tests.
Mr Han**** also told the health and social care committee that he does not expect another national lockdown to be needed before the arrival of mass vaccination against coronavirus, hopefully in the spring. He said in future, “we can rely on the tiered system”